US Bancorp
IRON icon

US Bancorp’s Disc Medicine IRON Stock Holding History

US Bancorp’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.9K Buy
1,229
+44
+4% +$3.02K ﹤0.01% 2511
2026
Q1 		$75.8K Buy
1,185
+9
+0.8% +$625 ﹤0.01% 2521
2025
Q4 		$93.4K Hold
1,176
– – ﹤0.01% 2410
2025
Q3 		$77.7K Sell
1,176
-3
-0.3% -$178 ﹤0.01% 2467
2025
Q2 		$62.4K Sell
1,179
-24
-2% -$1.13K ﹤0.01% 2672
2025
Q1 		$59.7K Buy
1,203
+27
+2% +$1.5K ﹤0.01% 2660
2024
Q4 		$74.6K Hold
1,176
– – ﹤0.01% 2529
2024
Q3 		$57.8K Hold
1,176
– – ﹤0.01% 2661
2024
Q2 		$53K Hold
1,176
– – ﹤0.01% 2645
2024
Q1 		$73.2K Hold
1,176
– – ﹤0.01% 2508
2023
Q4 		$67.9K Hold
1,176
– – ﹤0.01% 2512
2023
Q3 		$55.2K Hold
1,176
– – ﹤0.01% 2396
2023
Q2 		$52.2K Hold
1,176
– – ﹤0.01% 2479
2023
Q1 		$24.9K Hold
1,176
– – ﹤0.01% 2879
2022
Q4 		$23.4K Buy
+1,176
New +$58.6K ﹤0.01% 2914

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

US Bancorp's IRON Position: Q2 2026 in Review

US Bancorp increased its Disc Medicine (IRON) stake by 3.7% in Q2 2026, buying an estimated $3.02K and bringing the position to 1,229 shares worth $89.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

US Bancorp first reported a position in IRON in Q4 2022 and has held it in 15 quarters since. The position peaked at $93.4K in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • US Bancorp held 1,229 shares of Disc Medicine worth $89.9K as of Q2 2026.
  • US Bancorp bought 44 Disc Medicine shares in Q2 2026, an estimated $3.02K.
  • Disc Medicine made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2511 holding.
  • US Bancorp first reported a position in Disc Medicine in Q4 2022 and has held it in 15 quarters since.
  • US Bancorp's Disc Medicine position peaked at $93.4K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.